Determinants of the Empiric Use of Antibiotics by General Practitioners in South Africa: Observational, Analytic, Cross-Sectional Study.

South Africa antimicrobial resistance diagnostic uncertainty empiric antibiotic prescribing general practitioners guidelines

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
17 Oct 2022
Historique:
received: 04 09 2022
revised: 11 10 2022
accepted: 12 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

The overuse of antibiotics is the main driver of antimicrobial resistance (AMR). However, there has been limited surveillance data on AMR and antibiotic prescribing at a primary healthcare level in South Africa. An observational, analytic, cross-sectional study was undertaken to assess key factors associated with empiric antibiotic prescribing among private sector general practitioners (GPs) in the eThekwini district in South Africa, particularly for patients with acute respiratory infections (ARIs). A semi-structured web-based questionnaire was used between November 2020−March 2021. One hundred and sixteen (55.5%) responding GPs prescribed antibiotics empirically for patients with ARIs more than 70% of the time, primarily for symptom relief and the prevention of complications. GPs between the ages of 35−44 years (OR: 3.38; 95%CI: 1.15−9.88), >55 years (OR: 4.75; 95% CI 1.08−21) and in practice < 15 years (OR: 2.20; 95%CI: 1.08−4.51) were significantly more likely to prescribe antibiotics empirically. Three factors—workload/time pressures; diagnostic uncertainty, and the use of a formulary, were significantly associated with empiric prescribing. GPs with more experience and working alone were slightly less likely to prescribe antibiotics empirically. These findings indicate that a combination of environmental factors are important underlying contributors to the development of AMR. As a result, guide appropriate interventions using a health system approach, which includes pertinent prescribing indicators and targets.

Identifiants

pubmed: 36290081
pii: antibiotics11101423
doi: 10.3390/antibiotics11101423
pmc: PMC9598257
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Trop Med Int Health. 2021 May;26(5):504-517
pubmed: 33452857
Paediatr Int Child Health. 2015 Feb;35(1):5-13
pubmed: 24621245
Antibiotics (Basel). 2020 Aug 29;9(9):
pubmed: 32872419
Int J Clin Pharm. 2019 Oct;41(5):1348-1358
pubmed: 31273588
JAMA Netw Open. 2018 Jun 1;1(2):e180243
pubmed: 30646067
Eur J Gen Pract. 2013 Jun;19(2):85-91
pubmed: 23072550
Life (Basel). 2021 Jun 07;11(6):
pubmed: 34200116
J Infect. 2019 Jan;78(1):8-18
pubmed: 29981773
Afr Health Sci. 2020 Sep;20(3):1133-1142
pubmed: 33402958
JAMA Intern Med. 2014 Dec;174(12):2029-31
pubmed: 25286067
Basic Clin Pharmacol Toxicol. 2015 Feb;116(2):146-57
pubmed: 25052464
J Glob Antimicrob Resist. 2022 Jun;29:542-550
pubmed: 34915203
Lancet Glob Health. 2016 Sep;4(9):e633-41
pubmed: 27495137
JAC Antimicrob Resist. 2021 Jun 14;3(2):dlab080
pubmed: 34223139
Int J Antimicrob Agents. 2020 Dec;56(6):106189
pubmed: 33045348
Expert Rev Anti Infect Ther. 2017 Oct;15(10):963-972
pubmed: 28922959
Expert Opin Drug Saf. 2022 Aug;21(8):1089-1111
pubmed: 35876080
Eur J Gen Pract. 2014 Jun;20(2):114-20
pubmed: 23998298
BMJ. 2019 Dec 11;367:l6461
pubmed: 31826860
Clin Microbiol Infect. 2021 Apr;27(4):520-531
pubmed: 33418017
Target Oncol. 2018 Dec;13(6):725-733
pubmed: 30446872
J Antimicrob Chemother. 2016 Jun;71(6):1707-14
pubmed: 26945710
Antibiotics (Basel). 2022 Aug 22;11(8):
pubmed: 36010008
Perspect Public Health. 2021 Jan;141(1):19-27
pubmed: 31633458
Am J Med Qual. 2008 Jan-Feb;23(1):39-46
pubmed: 18187589
Ann Fam Med. 2014 Jul;12(4):344-51
pubmed: 25024243
Antibiotics (Basel). 2021 Aug 17;10(8):
pubmed: 34439046
Glob Health Action. 2017;10(1):1327638
pubmed: 28590792
Syst Rev. 2018 Jul 21;7(1):102
pubmed: 30031404
BMJ Open Qual. 2018 Nov 20;7(4):e000217
pubmed: 30555928
S Afr Med J. 2017 Jan 30;107(2):119-122
pubmed: 28220736
Lancet Infect Dis. 2021 Jan;21(1):107-115
pubmed: 32717205
PLoS One. 2017 Dec 21;12(12):e0189621
pubmed: 29267306
JAMA Intern Med. 2013 Feb 25;173(4):267-73
pubmed: 23319069
JAC Antimicrob Resist. 2019 Nov 12;1(3):dlz072
pubmed: 34222945
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Curr Med Res Opin. 2020 Feb;36(2):301-327
pubmed: 31794332
Europace. 2021 Nov 8;23(11):1722-1730
pubmed: 34096584
BMJ Glob Health. 2019 Aug 15;4(4):e001590
pubmed: 31497315
BMJ Open. 2019 Sep 4;9(9):e027059
pubmed: 31488467
Pediatr Infect Dis J. 2016 Dec;35(12):1317-1323
pubmed: 27626915
BMJ Qual Saf. 2011 Mar 21;20(9):764-772
pubmed: 21441602
Expert Rev Anti Infect Ther. 2018 May;16(5):381-384
pubmed: 29672172
PLoS One. 2022 Aug 1;17(8):e0272375
pubmed: 35913964
Scand J Prim Health Care. 2010 Mar;28(1):4-11
pubmed: 20331386
BMJ Open. 2013 Apr 11;3(4):
pubmed: 23585394
Infect Control Hosp Epidemiol. 2022 Sep;43(9):1238-1241
pubmed: 34112273
Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):509-15
pubmed: 18695594
JAMA. 2016 Feb 9;315(6):562-70
pubmed: 26864410
Int J Epidemiol. 2016 Jun;45(3):714-715f
pubmed: 27165758
S Afr J Infect Dis. 2021 Apr 21;36(1):262
pubmed: 34485504
Antimicrob Resist Infect Control. 2019 Aug 7;8:132
pubmed: 31406571
Proc Natl Acad Sci U S A. 2018 Apr 10;115(15):E3463-E3470
pubmed: 29581252
Expert Rev Anti Infect Ther. 2015;13(12):1547-56
pubmed: 26358203
Basic Clin Pharmacol Toxicol. 2011 Apr;108(4):224-33
pubmed: 21414143
Health Policy. 2010 May;95(2-3):236-44
pubmed: 20047773
Int J Qual Health Care. 2019 Jun 1;31(5):338-345
pubmed: 30169688
Lancet Infect Dis. 2018 Jan;18(1):18-20
pubmed: 29303731
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:73-8
pubmed: 23640191
J Med Assoc Thai. 2014 Mar;97 Suppl 3:S13-9
pubmed: 24772576
Lancet Infect Dis. 2019 Dec;19(12):1278-1280
pubmed: 31782385
Trop Med Infect Dis. 2021 Sep 13;6(3):
pubmed: 34564550
Eur J Clin Pharmacol. 2006 Feb;62(2):135-42
pubmed: 16389536
BMJ Open Qual. 2018 Dec 16;7(4):e000495
pubmed: 30623113
Front Pharmacol. 2019 Mar 05;9:1156
pubmed: 30890943
Expert Rev Pharmacoecon Outcomes Res. 2010 Dec;10(6):707-22
pubmed: 21155704
Health Policy. 2010 Mar;94(3):221-9
pubmed: 19879009
Int J Clin Pract. 2017 Dec;71(12):
pubmed: 29178350
Antibiotics (Basel). 2022 Aug 12;11(8):
pubmed: 36009960
Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):65-83
pubmed: 19371180
Br J Gen Pract. 2014 Feb;64(619):e75-80
pubmed: 24567620
Expert Rev Anti Infect Ther. 2021 Apr;19(4):537-546
pubmed: 32990480
BMJ Open. 2017 May 2;7(4):e014345
pubmed: 28465306
Malays J Med Sci. 2019 Jul;26(4):101-109
pubmed: 31496899
Antimicrob Resist Infect Control. 2022 Aug 30;11(1):111
pubmed: 36042483
PLoS Med. 2020 Jun 16;17(6):e1003139
pubmed: 32544153
PLoS One. 2021 Apr 1;16(4):e0249475
pubmed: 33793627
Antibiotics (Basel). 2022 May 14;11(5):
pubmed: 35625305
Trop Med Int Health. 2006 May;11(5):765-72
pubmed: 16640631
Front Pharmacol. 2017 Nov 09;8:751
pubmed: 29163151
Nepal Med Coll J. 2009 Dec;11(4):217-21
pubmed: 20635596
Int J Infect Dis. 2017 Nov;64:100-106
pubmed: 28893672
Bangladesh Med Res Counc Bull. 2007 Apr;33(1):21-30
pubmed: 18246731
S Afr Med J. 2018 Mar 28;108(4):304-310
pubmed: 29629681
Int J Clin Pharm. 2020 Aug;42(4):1227-1236
pubmed: 32458227
J Antimicrob Chemother. 2018 Jun 1;73(suppl_6):vi40-vi49
pubmed: 29878218
Vaccines (Basel). 2022 Sep 17;10(9):
pubmed: 36146631
Antimicrob Resist Infect Control. 2018 Oct 4;7:119
pubmed: 30323922
BMJ Open. 2018 May 14;8(5):e021517
pubmed: 29764887
J Int Med Res. 2018 Aug;46(8):3337-3357
pubmed: 29962311
Fam Pract. 2005 Apr;22(2):215-22
pubmed: 15722398
J Glob Antimicrob Resist. 2018 Jun;13:240-245
pubmed: 29414723
BMC Fam Pract. 2018 Nov 17;19(1):175
pubmed: 30447685
Sci Rep. 2016 Mar 24;6:23429
pubmed: 27010107
Lancet. 2013 Oct 5;382(9899):1175-82
pubmed: 23915885
Br J Gen Pract. 2018 Sep;68(674):e633-e645
pubmed: 29914880
PLoS One. 2017 Apr 14;12(4):e0174566
pubmed: 28410366
J Antimicrob Chemother. 2020 Jan 1;75(1):14-29
pubmed: 31834401
Microb Drug Resist. 2021 Dec;27(12):1705-1725
pubmed: 34077290
S Afr Med J. 2018 Aug 28;108(9):763-771
pubmed: 30182902
BMC Fam Pract. 2011 Aug 10;12:85
pubmed: 21831317
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Antibiotics (Basel). 2020 Aug 09;9(8):
pubmed: 32784880
Expert Rev Anti Infect Ther. 2015 May;13(5):665-80
pubmed: 25813839
EMBO Rep. 2020 Dec 3;21(12):e51034
pubmed: 33400359
J Antimicrob Chemother. 2011 Oct;66(10):2425-33
pubmed: 21784782
Hosp Pract (1995). 2022 Oct;50(4):306-317
pubmed: 35980901
J Antimicrob Chemother. 2018 Feb 1;73(suppl_2):ii11-ii18
pubmed: 29490061
BMC Public Health. 2015 Aug 01;15:742
pubmed: 26231758
Front Public Health. 2021 Dec 09;9:741345
pubmed: 34957007
Medicine (Baltimore). 2018 Dec;97(51):e13719
pubmed: 30572507
Med J Malaysia. 2006 Aug;61(3):323-31
pubmed: 17240584
Br J Gen Pract. 2017 Mar;67(656):e168-e177
pubmed: 28093423
Lancet Glob Health. 2018 Jun;6(6):e619-e629
pubmed: 29681513
Health Aff (Millwood). 2014 Mar;33(3):502-10
pubmed: 24572187
Implement Sci. 2018 Mar 20;13(1):47
pubmed: 29554972
Front Pharmacol. 2020 Sep 11;11:1205
pubmed: 33071775
Fam Pract. 2010 Dec;27(6):684-90
pubmed: 20660529
Hosp Pract (1995). 2021 Aug;49(3):184-193
pubmed: 33566710
Ther Adv Drug Saf. 2014 Dec;5(6):229-41
pubmed: 25436105
BMC Fam Pract. 2019 Feb 14;20(1):27
pubmed: 30764777
NPJ Prim Care Respir Med. 2021 Mar 25;31(1):17
pubmed: 33767206
PLoS Med. 2019 Feb 5;16(2):e1002733
pubmed: 30721234
PLoS One. 2013 May 10;8(5):e63225
pubmed: 23675465
BMJ Open. 2015 Jul 15;5(7):e008096
pubmed: 26179648
Healthcare (Basel). 2021 Dec 13;9(12):
pubmed: 34946448
Int J Clin Pract. 2017 Feb;71(2):
pubmed: 28090718
BMJ. 2013 Jul 26;347:f4403
pubmed: 23894178
Front Pharmacol. 2014 Oct 08;5:219
pubmed: 25339902
BMC Pulm Med. 2021 Nov 15;21(1):374
pubmed: 34781920
Expert Rev Anti Infect Ther. 2015 Apr;13(4):511-20
pubmed: 25704246

Auteurs

Sinenhlanhla Pearl Guma (SP)

Discipline of Public Health Medicine, 227 George Campbell Building, Howard College Campus, University of KwaZulu-Natal, Durban 4001, South Africa.

Brian Godman (B)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
Centre of Medical and Bio-allied Health Sciences Research, Ajman University, Ajman P.O. Box 346, United Arab Emirates.
Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Science (SIPBS), University of Strathclyde, Glasgow G4 0RE, UK.

Stephen M Campbell (SM)

Department of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0204, South Africa.
Centre for Epidemiology and Public Health, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.
NIHR Greater Manchester Patient Safety Translational Research Centre, School of Health Sciences, University of Manchester, Manchester M13 9PL, UK.

Ozayr Mahomed (O)

Discipline of Public Health Medicine, 227 George Campbell Building, Howard College Campus, University of KwaZulu-Natal, Durban 4001, South Africa.

Classifications MeSH